Mucocutaneous manifestations of Behcet's disease

被引:0
作者
Uva, Luis [1 ]
Miguel, Diana [1 ]
Pinheiro, Catarina [1 ]
Filipe, Paulo [1 ]
Freitas, Joao Pedro [1 ]
机构
[1] Fac Med Lisbon, Clin Univ Dermatol, P-1649035 Lisbon, Portugal
来源
ACTA REUMATOLOGICA PORTUGUESA | 2013年 / 38卷 / 02期
关键词
Behcet's disease; Epidemiology; Etiopathogenesis; Cutaneous manifestations; Diagnostic criteria; Treatment; NODOSUM-LIKE LESIONS; GENOME-WIDE ASSOCIATION; HERPES-SIMPLEX-VIRUS; HEAT-SHOCK-PROTEIN; DOUBLE-BLIND TRIAL; HISTOPATHOLOGIC FEATURES; SYMPTOMS; THERAPY; CYCLOSPORINE; THALIDOMIDE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet's disease is a relapsing multisystem polysymptomatic disease with exacerbations and remissions defined by the presence of the major symptom, recurrent oral aphthous ulcers, plus two of the following: recurrent genital ulceration, eye lesions, skin lesions or a positive pathergy test. Mucocutaneous manifestations like oral and genital ulcers, and cutaneous lesions (papulopustular lesions, erythema nodosum-like lesions, cutaneous ulcers, superficial thrombophlebitis), are considered the "fingerprint" of the disease, being the most common and often the first signs to appear. Although the exact etiopathogenesis is still not known, genetic predisposition and environmental factors may influence and contribute to the development of this disease. Diagnosis is based on the International Study Group criteria. During the last years, this disease has been largely studied and new immunological data and treatment strategies have been postulated. Despite that, further studies and attention to new data are needed.
引用
收藏
页码:77 / 90
页数:14
相关论文
共 50 条
  • [1] Mucocutaneous Manifestations of Behcet's Disease
    Boyvat, Ayse
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2009, 43 : 42 - 47
  • [2] Behcet's disease - Infliximab in the treatment of mucocutaneous manifestations
    Lestre, Sara
    Trindade, Felicidade
    Martins, Andrea
    Baptista, Juliana
    Feio, Ana Barata
    Paiva Lopes, Maria Joao
    ACTA REUMATOLOGICA PORTUGUESA, 2009, 34 (04): : 633 - 640
  • [3] Mucocutaneous manifestations of Behcet's disease: Pathogenesis and management from perspectives of vasculitis
    Kim, Doyoung
    Nakamura, Koichiro
    Kaneko, Fumio
    Alpsoy, Erkan
    Bang, Dongsik
    FRONTIERS IN MEDICINE, 2022, 9
  • [4] Mucocutaneous lesions of Behcet's disease
    Alpsoy, Erkan
    Zouboulis, Christos Constantin
    Ehrlich, George Edward
    YONSEI MEDICAL JOURNAL, 2007, 48 (04) : 573 - 585
  • [5] A new Mucocutaneous Activity Index for Behcet's disease
    Mumcu, G.
    Inanc, N.
    Taze, A.
    Ergun, T.
    Direskeneli, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (04) : S80 - S86
  • [6] Behcet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions
    Alpsoy, Erkan
    JOURNAL OF DERMATOLOGY, 2016, 43 (06) : 620 - 632
  • [7] Behcet's disease: Treatment of mucocutaneous lesions
    Alpsoy, E
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (04) : 532 - 539
  • [8] Pathergy reaction in Behcet's disease: Lack of correlation with mucocutaneous manifestations and systemic disease expression
    Krause, I
    Molad, Y
    Mitrani, M
    Weinberger, A
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (01) : 71 - 74
  • [9] Interferon Alfa-2b Therapy in Mucocutaneous Manifestations of Behcet's Disease
    Rezaieyazdi, Z.
    Shoja-e-razavi, G.
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2005, 30 (03) : 105 - 109
  • [10] Cardiac manifestations in Behcet's disease
    Demirelli, Selami
    Degirmenci, Husnu
    Inci, Sinan
    Arisoy, Arif
    INTRACTABLE & RARE DISEASES RESEARCH, 2015, 4 (02) : 70 - 75